Tag: life sciences
-
Patch Delivers Low-Dose Vaccine with Full-Dose Power
A clinical trial shows a polymer patch with one-sixth of the usual influenza vaccine dose generates about the same immune reaction as a full-dose injection.
-
Trial Testing Arthritis Drug as Covid-19 Treatment
A clinical trial is enrolling patients with severe novel coronavirus infections to test a synthetic antibody now approved to treat rheumatoid arthritis.
-
Commentary – Biotech, Trump’s Latest Casino
If you thought the Trump administration couldn’t bungle any worse its response to the coronavirus pandemic, think again.
-
Lilly, Biotech, NIH to Develop Covid-19 Antibodies
Drug maker Eli Lilly and Co., a biotechnology company, and an agency of NIH are collaborating on antibodies for novel coronavirus vaccines and therapies.
-
Engineered Probiotic Maker Gains $2.3M Seed Funding
A developer of genetically-modified bacteria designed to work in the gut is raising $2.3 million more in seed funds to expand its product line.
-
Gates Funding Covid-19 Vaccine Delivery Device
A biotechnology company developing a vaccine for the Covid-19 virus received funding to scale up a delivery device for the vaccine when it’s available.
-
Start-Up Developing Marine Bio-Inspired Super Glue
A new enterprise is creating an strong binding adhesive inspired by mussels, derived from research in a university chemistry and materials science lab.
-
Engineered Viruses Deployed to Treat Gut Infections
Academic and industry researchers created gene-editing viruses that in lab cultures and mice killed bacteria causing often deadly intestinal infections.
-
Business-Foundation Alliance Funds Covid-19 Treatments
Two foundations and a credit card company are providing seed money for development and manufacture of treatments for the novel coronavirus or Covid-19 pandemic.
-
FDA Okays MRI with Epilepsy Brain Stimulation
A company making brain stimulation systems to treat epilepsy received regulatory clearance for MRI scans in people with its implanted devices.